STAT3 activation upregulates anti-apoptotic proteins (e.g., Bcl-2) and promotes cell cycle progression through the regulation of cyclins and cyclin-dependent kinases, ultimately contributing to chemoresistance in tumor cells [6, 16–18, 20]. The gene discussed is STAT3; the disease is neoplasm.